Allan Hildesheim

34.5k total citations · 4 hit papers
338 papers, 22.6k citations indexed

About

Allan Hildesheim is a scholar working on Epidemiology, Surgery and Oncology. According to data from OpenAlex, Allan Hildesheim has authored 338 papers receiving a total of 22.6k indexed citations (citations by other indexed papers that have themselves been cited), including 216 papers in Epidemiology, 103 papers in Surgery and 99 papers in Oncology. Recurrent topics in Allan Hildesheim's work include Cervical Cancer and HPV Research (188 papers), Genital Health and Disease (73 papers) and Hepatitis B Virus Studies (68 papers). Allan Hildesheim is often cited by papers focused on Cervical Cancer and HPV Research (188 papers), Genital Health and Disease (73 papers) and Hepatitis B Virus Studies (68 papers). Allan Hildesheim collaborates with scholars based in United States, Costa Rica and France. Allan Hildesheim's co-authors include Rolando Herrero, Sholom Wacholder, Robert D. Burk, Mark Schiffman, Ana Cecilia Rodríguez, John T. Schiller, Mark E. Sherman, Cosette M. Wheeler, M. Concepción Bratti and Mark Schiffman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and JAMA.

In The Last Decade

Allan Hildesheim

331 papers receiving 21.9k citations

Hit Papers

Improved Amplification of Genital Human Papillomaviruses 1993 2026 2004 2015 2000 1993 1994 2013 250 500 750

Peers

Allan Hildesheim
Robert D. Burk United States
Nicolas Wentzensen United States
Mark H. Stoler United States
Mark E. Sherman United States
Anna R. Giuliano United States
Allan Hildesheim
Citations per year, relative to Allan Hildesheim Allan Hildesheim (= 1×) peers Joakim Dillner

Countries citing papers authored by Allan Hildesheim

Since Specialization
Citations

This map shows the geographic impact of Allan Hildesheim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allan Hildesheim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allan Hildesheim more than expected).

Fields of papers citing papers by Allan Hildesheim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allan Hildesheim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allan Hildesheim. The network helps show where Allan Hildesheim may publish in the future.

Co-authorship network of co-authors of Allan Hildesheim

This figure shows the co-authorship network connecting the top 25 collaborators of Allan Hildesheim. A scholar is included among the top collaborators of Allan Hildesheim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allan Hildesheim. Allan Hildesheim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sierra, Mónica S., Sabrina H. Tsang, Carolina Porras, et al.. (2022). Analysis of cervical HPV infections among unvaccinated young adult women to inform vaccine strategies in this age group: the Costa Rica HPV Vaccine Trial. Sexually Transmitted Infections. sextrans–2022.
2.
Jackson, Sarah S., Ruth M. Pfeiffer, Tram Kim Lam, et al.. (2022). Association between Immunologic Markers and Cirrhosis in Individuals from a Prospective Chronic Hepatitis C Cohort. Cancers. 14(21). 5280–5280. 1 indexed citations
3.
Yu, Kelly J., Wan‐Lun Hsu, Chun‐Ju Chiang, et al.. (2021). Cancer patterns in nasopharyngeal carcinoma multiplex families over 15 years. Cancer. 127(22). 4171–4176. 3 indexed citations
4.
Liu, Zhiwei, Chih-Jen Huang, Yu‐Han Huang, et al.. (2021). HLA Zygosity Increases Risk of Hepatitis B Virus-Associated Hepatocellular Carcinoma. The Journal of Infectious Diseases. 224(10). 1796–1805. 9 indexed citations
5.
Liu, Zhiwei, Andriy Derkach, Kelly J. Yu, et al.. (2020). Patterns of Human Leukocyte Antigen Class I and Class II Associations and Cancer. Cancer Research. 81(4). 1148–1152. 16 indexed citations
6.
Liu, Zhiwei, Ruth F. Jarrett, Henrik Hjalgrim, et al.. (2019). Evaluation of the antibody response to the EBV proteome in EBV‐associated classical Hodgkin lymphoma. International Journal of Cancer. 147(3). 608–618. 12 indexed citations
7.
Liu, Zhiwei, Troy J. Kemp, Yu‐Tang Gao, et al.. (2018). Association of circulating inflammation proteins and gallstone disease. Journal of Gastroenterology and Hepatology. 33(11). 1920–1924. 52 indexed citations
8.
Coghill, Anna E., Ruth M. Pfeiffer, Carla Proietti, et al.. (2018). Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan. Clinical Cancer Research. 24(6). 1305–1314. 47 indexed citations
9.
Liu, Zhiwei, Troy J. Kemp, Yu-Tang Gao, et al.. (2018). Circulating Levels of Inflammatory Proteins and Survival in Patients with Gallbladder Cancer. Scientific Reports. 8(1). 5671–5671. 14 indexed citations
10.
Coghill, Anna E., Wei Bu, Hanh Nguyen, et al.. (2016). High Levels of Antibody that Neutralize B-cell Infection of Epstein–Barr Virus and that Bind EBV gp350 Are Associated with a Lower Risk of Nasopharyngeal Carcinoma. Clinical Cancer Research. 22(14). 3451–3457. 32 indexed citations
11.
Loftfield, Erikka, Meredith S. Shiels, Barry I. Graubard, et al.. (2015). Associations of Coffee Drinking with Systemic Immune and Inflammatory Markers. Cancer Epidemiology Biomarkers & Prevention. 24(7). 1052–1060. 60 indexed citations
12.
Kuhs, Krystle A. Lang, Allan Hildesheim, Britton Trabert, et al.. (2015). Association between Regular Aspirin Use and Circulating Markers of Inflammation: A Study within the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiology Biomarkers & Prevention. 24(5). 825–832. 15 indexed citations
13.
Coghill, Anna E., Wan‐Lun Hsu, Ruth M. Pfeiffer, et al.. (2014). Epstein–Barr Virus Serology as a Potential Screening Marker for Nasopharyngeal Carcinoma among High-Risk Individuals from Multiplex Families in Taiwan. Cancer Epidemiology Biomarkers & Prevention. 23(7). 1213–1219. 52 indexed citations
14.
Kitahara, Cari M., Britton Trabert, Hormuzd A. Katki, et al.. (2014). Body Mass Index, Physical Activity, and Serum Markers of Inflammation, Immunity, and Insulin Resistance. Cancer Epidemiology Biomarkers & Prevention. 23(12). 2840–2849. 76 indexed citations
15.
Safaeian, Mahboobeh, Carolina Porras, Yuanji Pan, et al.. (2013). Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine Trial. Cancer Prevention Research. 6(11). 1242–1250. 159 indexed citations
16.
Yu, Kelly J., Wan-Lun Hsu, Ruth M. Pfeiffer, et al.. (2011). Prognostic Utility of Anti-EBV Antibody Testing for Defining NPC Risk among Individuals from High-Risk NPC Families. Clinical Cancer Research. 17(7). 1906–1914. 51 indexed citations
17.
Herrero, Rolando, Sholom Wacholder, Ana Cecilia Rodríguez, et al.. (2011). Prevention of Persistent Human Papillomavirus Infection by an HPV16/18 Vaccine: A Community-Based Randomized Clinical Trial in Guanacaste, Costa Rica. Cancer Discovery. 1(5). 408–419. 116 indexed citations
18.
Chaturvedi, Anil K., Troy J. Kemp, Ruth M. Pfeiffer, et al.. (2011). Evaluation of Multiplexed Cytokine and Inflammation Marker Measurements: a Methodologic Study. Cancer Epidemiology Biomarkers & Prevention. 20(9). 1902–1911. 87 indexed citations
19.
Kemp, Troy J., Allan Hildesheim, Alfonso Garcı́a-Piñeres, et al.. (2010). Elevated Systemic Levels of Inflammatory Cytokines in Older Women with Persistent Cervical Human Papillomavirus Infection. Cancer Epidemiology Biomarkers & Prevention. 19(8). 1954–1959. 68 indexed citations
20.
Sengupta, Srikumar, Johan A. den Boon, I‐How Chen, et al.. (2006). Genome-Wide Expression Profiling Reveals EBV-Associated Inhibition of MHC Class I Expression in Nasopharyngeal Carcinoma. Cancer Research. 66(16). 7999–8006. 194 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026